Brief: Exicure Granted Two Fast Track Designations For Cavrotolimod From The U.S. Food And Drug Administration
Jan 11 (Reuters) - Exicure Inc XCUR.O :
* EXICURE GRANTED TWO FAST TRACK DESIGNATIONS FOR
CAVROTOLIMOD
(AST-008) FROM THE U.S. FOOD AND DRUG ADMINISTRATION
* EXICURE INC -FAST TRACK DESIGNATION GRANTED FOR
CAVROTOLIMOD IN
COMBINATION WITH ANTI-PROGRAMMED DEATH-1 (PD-1) THERAPY
* EXICURE INC - FAST TRACK DESIGNATION GRANTED FOR
CAVROTOLIMOD IN
COMBINATION WITH ANTI-PD-1/ANTI-PD-LIGAND 1 (ANTI-PD-(L)1)
THERAPY
Source text for Eikon: ID:nBw1Sb7nca
Further company coverage: XCUR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exicure
See all newsBrief: Exicure Announces 1-For-5 Reverse Stock Split
U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase
Brief: Exicure Inc Says Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-K
Brief: Exicure And Bluejay Therapeutics Enter Into A Patent License Agreement To Develop Cavrotolimod For The Treatment Of Hepatitis
Brief: Exicure Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq